Most cited papers in Chemotherapy-induced cardiotoxicity and mitigation

The most cited paper in Chemotherapy-induced cardiotoxicity and mitigation is "Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer" (Sarah C. Darby, Marianne Ewertz, Paul McGale et al., 2013), with 4,034 citations. Next come "Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity" (3,790) and "2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)" (3,050).

Showing 50 of 96 papers. Every paper with more than 731 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.